# Sagetis Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sagetis-biotech

- Industry: Biotechnology
- Headquarters: Barcelona, Spain
- Website: www.biocat.cat
- Total disclosed funding: $2M
- Latest round: Series B (Jul 18, 2011)
- Investors on record: 1

## About

Sagetis Biotech is a research-driven company focused on advancing biotechnological innovations in healthcare, emphasizing transformative developments in life sciences and health technology.Founded in Barcelona, Spain, in 2010, Sagetis Biotech specializes in biotechnological research and product development. The company has completed 2 strategic funding deals, with its latest round being a Series B financing of USD 2.000 mn led by Caixa Capital Risc on July 18, 2011, which represents the total amount raised to date. The founder's history and previous ventures are not disclosed.Sagetis Biotech is integral to the BioRegió of Catalonia, facilitating the growth of the life sciences and health innovation ecosystem. The company offers various programs aimed at supporting biomedical research projects, startups, and established firms in health technology. Services include business idea validation, internationalization support, and targeted training to enhance entrepreneurial skills for careers within health innovation sectors, serving a diverse clientele of researchers, corporates, and investors.In 2017, Sagetis Biotech reported a revenue of USD 55,998.30, with an EBITDA of USD -163,636.30, reflecting its operating performance in the health innovation sector.Looking ahead, Sagetis Biotech aims to expand its product offerings and launch new innovations in the health technology arena. The company plans to penetrate additional European markets by leveraging the recent Series B funding of USD 2.000 mn. This capital will support the development of new programs and enhance existing services, while also fostering strategic partnerships to facilitate growth in new geographic regions.

## Funding rounds

- Series B, Jul 18, 2011, $2M — Caixa Capital Risc

## Investors

- Caixa Capital Risc — Series B